APA (7th ed.) Citation

M, G., H, H., T, H., S, B., N, P., D, G., . . . AC, O. (2025). Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update. BMC nephrology, 26(1), 79. https://doi.org/10.1186/s12882-025-03960-4

Chicago Style (17th ed.) Citation

M, Gittus, et al. "Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an Update." BMC Nephrology 26, no. 1 (2025): 79. https://doi.org/10.1186/s12882-025-03960-4.

MLA (9th ed.) Citation

M, Gittus, et al. "Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an Update." BMC Nephrology, vol. 26, no. 1, 2025, p. 79, https://doi.org/10.1186/s12882-025-03960-4.